AstraZeneca’s Dapagliflozin gets approval for Chronic Kidney Disease in India
New Delhi: AstraZeneca India (AstraZeneca Pharma India Limited), a leading science-led biopharmaceutical company, today announced that they have received marketing authorisation for their anti-diabetic drug dapagliflozin, in India for the…